Sarasota fertility company completes merger with bioscience firm

Combining the two Florida companies has the "potential to create significant value," CEO Steve Shun says in a statement.

By Elizabeth King
| 2:09 p.m. October 14, 2024
| 0 Free Articles Remaining!

INVO Bioscience offers what it calls assisted reproductive technology to women trying to get pregnant.

Manatee-Sarasota

A Sarasota-based fertility company has merged with a bioscience business to form a publicly traded company.

INVO Bioscience, which focuses on fertility treatments and clinics and is traded under the name INVO, completed its merger with Aventura-headquartered NAYA Biosciences, a company dedicated to oncology treatment and regenerative medicine, according to an Oct. 14 statement.

The combined company will be called NAYA Biosciences, trading under the NAYA ticker on the Nasdaq, and it will engage in the fertility business as well as clinical-stage treatments for oncology and autoimmune diseases.